简介:Lophenol,cholest-4α-methyl-7-en-3β-ol(1),obtainedfromDracaenacochinchinensis(Lour.)S.C.Chen,wasstructurallymodified.Itwasacetylatedtoprotect3β-hydroxylgroup,andthenoxidisedbyseleniumdioxideinaceticacidtogivecholest-4a-methyl-8-en-3β,Ta-dioldiacetate(3).Thiscompound3isunstableinchloroformsolutionorwhenheatedandeasilyconvertedtoadienecompound,cholest-4a-methyl-7,14-dien-3β-olacetate(4).Thestructuresof3and4wereelucidatedbymeansofIR,^1HNMR,^13CNMRandMS,andtheabsoluteconfigurationof3wasestablishedbyX-raycrystallography.Thepropertyof3wasalsodiscussedinthispaper.Both3and4arenewcompoundsandwerereportedforthefirsttime.
简介:标题化合物C22H29N3O3以简单易得的试剂为原料,在乙醇溶剂中,微波辐射下经两步多组分反应合成得到.其结构通过单晶X射线衍射法确定,晶体属三斜晶系,空间群P-1,相对分子质量Mr=383.48,晶胞参数a=1.14770(12)nm,b=2.0657(2)nm,c=1.00780(12)nm,V=2.1841(4)nm3,Z=4,晶胞密度Dc=1.166mg/m3,吸收系数μ=0.078mm-1,单胞中电子的数目F(000)=824.晶体结构用直接法解出,经全矩阵最小二乘法对原子参数进行修正,最终的偏离因子为R1=0.0709,wR2=0.1405.在晶体结构中新形成的噌啉环为近似于共平面结构,而其中的哒嗪环则为船式构象.
简介:Reactionsofthe6-hydroxy-thiopyrano[3,4-c]pyridine-5-carbonitrilederivative1withα-halo-carbonylcompoundsgavetheortho-substitutedintermediates2a-cwhichwereconvertedintofuro[2,3-b]thiopyrano[4,3-d]pyridines3a-cbyfusionofafuranmoietyunderbasicconditions.Furthercyclizationof3a-cledtoafusionofapyrimidinering,yieldingthetetracyclicproducts6,7and8.Inaddition,condensationof6withvariousaromaticaldehydesaffordedthecorrespondingimines9a,b.Mannichreactionof7gaveproducts10a,b.
简介:标题化合物(C24H16N4S)以噻吩-2-甲醛、苯甲酰乙腈和3-甲基-1-苯基-1H-吡唑-5-胺为原料,在离子液体[bmim]Br溶剂中,在80℃搅拌合成得到.其结构通过单晶X射线衍射法确定,晶体属于三斜晶系,空间群P-1,相对分子质量Mr=392.47,晶胞参数a=0.93612(8)nm,b=1.03063(12)nm,c=1.16624(16)nm,V=0.96853(19)nm3,Z=2,晶胞密度Dc=1.346g/cm3,吸收系数μ=0.185mm-1,单胞中电子的数目F(000)=408.晶体结构用直接法解出,经全矩阵最小二乘法对原子参数进行修正,最终的偏离因子R=0.0585,wR=0.1337.在晶体结构中新形成的吡啶环与吡唑环近似于共平面结构.
简介:综合运用密度泛函理论、分子力学、统计学及比较分子力场分析等方法研究了抗肿瘤药物5,8-二甲基乙酰紫草素衍生物的二维(2D)、三维(3D)定量构效关系(QSAR).所建最优2D-QSAR方程的交叉验证系数(q^2)和拟合相关系数(R^2)分别为0.618和0.736.CoMFA模型的q^2和非交叉验证系数(r^2)分别为0.703和0.982,预测相关系数R^2pred为0.746.结果表明,所建立的2D/3D-QSAR模型都具有良好的统计学意义及合理、可信的预报能力,可以预测未知化合物的活性。基于此研究结果,设计了4个具有较高抗肿瘤活性的新化合物.
简介:ThecomplexK3H4GeW9V3O40·8H2OcrystallizedinamonocliiniesystemwithspacegroupP2,Mr=2784.67,a=11.099(3),b=16.452(4),c=13.534(4),β=108.14°,Z=2,V=2348.493,F(000):2456,μ=239.7cm-1,De=3.932g/cm3.ThefinalR=0.083for4528non-zeroreflexions.ThestructureofanionsGeW9V3O40andGeW9O34belongstoA--type.
简介:Pureandneodymium-dopedgadoliniumcalciumoxoboratecrystalsofhighqualityweregrownbytheCzochralskimethod.Theorientationofcrystalwaspreciselydetermined,andthesamplesformeasurementswereprepared.Throughsynchrotronx-raytopographyandhigh-resolutionx-raydiffractometry,thetwinstructurewasdiscovered.Somepropertiessuchasthefigureofmeritvalue,anddielectric,piezoelectric,andelasticconstantsweremeausuredalongwithadiscussionoftheanisotropyofthelaserproperties.
简介:At-hyperwheel(t≥3)oflengthl(orW(t)lforbrevity)isat-uniformhypergraph(V,E),whereE={e1,e2,...,el}andv1,v2,...,vlaredistinctverticesofV=∪eii=1lsuchthatfori=1,...,l,vi,vi+1∈eiandei∩ej=P,j∈/{i1,i,i+1},wheretheoperationonthesubscriptsismodulolandPisavertexofVwhichisdifferentfromvi,1≤i≤l.Inthispaper,theminimumcoveringproblemofMCλ(3,W(3)4,v)isinvestigated.DirectandrecursiveconstructionsonMCλ(3,W(3)4,v)arepresented.Thecoveringnumbercλ(3,W(3)4,v)isfinallydeterminedforanypositiveintegersv≥5andλ.
简介:Treatmentof4-amino-3-(1-aryl-5-methyl-1,2,3-triazol-4-yl)-5-mercapto-1,2,4-triazoles/2-amino-5-(1-aryl-5-methyl-1,2,3-triazole-4-yl)-1,3,4-thiadiazoleswithbenzaldehyde,acetoneandω-bromoacetophenonewastestedandcompared.ThetitlecompoundsSchiffbases,amides,imidazolo[2,1-b]-1,3,4-thiadiazolesand7H-s-triazolo[3,4-b]-1,3,4-thiadiazineshavebeenconfirmedbyelementalanalyses,^1HNMR,IRandMSspectra.AllthecompoundshavealsobeenscreenedfortheirantibacterialactivitiesagainstB.subtilis,S.aureusandE.coli.
简介:利用L-脯氨酸催化的5-氯水杨醛(1)与6-甲基-4-羟基吡喃酮(2)的缩合反应及硫酸铜催化下与1,3-二甲基-5-氨基吡唑(3)的串联反应,合成得到了10-氯-1,3-二甲基-5-(2-氧代丙基)色烯并[4,3-d]吡唑并[3,4-b]吡啶-6(3H)-酮(4)和10-氯-5-二乙氧基甲基-1,3-二甲基色烯并[4,3-d]吡唑并[3,4-b]吡啶-6(3H)-酮(5).化合物5的结构通过单晶X射线衍射法确定:晶体属于三斜晶系,空间群P-1;相对分子质量Mr=803.68;晶胞参数a=1.03160(10)nm,b=1.42900(13)nm,c=1.44268(15)nm;V=1.9448(3)nm~3;Z=2;晶胞密度Dc=1.372g/cm~3;吸收系数μ=0.228mm-1;单胞中电子的数目F(000)=840.晶体结构用直接法解出,经全矩阵最小二乘法对原子参数进行修正,最终的偏离因子为R=0.0681,wR=0.2051.在晶体结构中色烯环与吡啶环及吡唑环近似于共平面.
简介:采用对称性破损态方法结合密度泛函理论,选用反铁磁双核配合物[Cu2(MMBPT)2Cl4(H2O)2.5](MMBPT=3-甲基-4-对甲基苯基-5-(2-吡啶)-1,2,4-三唑)作为研究对象,通过与实验数据相比较,探讨了不同密度泛函方法与基组对计算铜配合物交换耦合常数的准确度.结果表明,4种混合密度泛函DFT(B3LYP,B3P86,B3PW91和PBE0)的计算结果都能和实验所观察到的值-31cm-1符号一致,但只有B3PW91方法得到的结果和实验结果吻合程度最好,同时采用方法B3PW91方法计算所得的交换耦合常数Jab对基组的依赖性较大.研究表明,2个Cu(Ⅱ)离子之间弱的反铁磁相互作用主要源于单占据分子轨道SOMOs小的能量劈裂.
简介:Tris)(η5-cyclopentadienyl-μ-carbonyl-iron)-μ3-nitrosylclusterwasobtainedfromthereactionofcyclopentadienyldicarbonylirondimerwithnitrogenmonoxideinxylene.Theclusterwascharacterizedbyelementalanalyses,IR,MSand1HNMR.Thecrystalstructureof[(η5-C5H5)(μ-CO)Fe]3(μ3-NO).C4H8OwasdeterminedbyX-raydiffractionanalysis.ItcrystallizesintheorthorhombicspacegroupPnma,a=9.053(2),6=10.545(2),c=22.525(4)A,V=2150.3(7)A3,Z=4,Dc=1.68g.cm-3;structuresolutionandrefinementbasedon1141reflectionswithI>3.0(I)(MoKa,A=0.71073A)convergedatR=0.0540.Theinfraredabsorptionbandat1325cm-1oftheμ3-NOinthecluster,whichisredshifted,showsthatμ3-NOisactivated.
简介:DrugsSPD-304(6,7-dimethyl-3-{[methyl-(2-{methyl-[1-(3-trifluoromethyl-phenyl)-1H-indol-3-ylmethyl]-amino}-ethyl)-amino]-methyl}-chromen-4-one)andzafirlukastcontainacommonstructuralelementof3-substitutedindolemoietywhichcloselyrelatestoadehydrogenatedreactioncatalyzedbycytochromeP450s(CYPs).ItwasreportedthatthedehydrogenationcanproduceareactiveelectrophilicintermediatewhichcausetoxicitiesandinactivateCYPs.DrugL-745,870(3-{[4-(4-chlorophenyl)piperazin-1-yl]-methyl}-1H-pyrrolo2,3-β-pyridine)mighthavesimilareffectsinceitcontainsthesamestructuralelement.Weusedmoleculardockingapproachcombinedwithmoleculardynamics(MD)simulationtomodelthree-dimensional(3D)complexstructuresofSPD-304,zafirlukastandL-745,870intoCYP3A4,respectively.Theresultsshowthatthesethreedrugscanstablybindintotheactivesiteandthe3-methylenecarbonsofthedrugskeepareasonablereactivedistancefromthehemeiron.ThecomplexstructureofSPD-304-CYP3A4isinagreementwithexperimentaldata.Forzafirlukast,thecalculationresultsindicatethat3-methylenecarbonmightbethedehydrogenationreactionsite.DockingmodelofL-745,870-CYP3A4showsapotentialpossibilityofL-745,870dehydrogenatedbyCYP3A4at3-methylenecarbonwhichisinagreementwithexperimentinvivo.Inaddition,residuesinthephenylalanineclusteraswellasS119andR212playacriticalroleintheligandsbindingbasedonourcalculations.ThedockingmodelscouldprovidesomecluestounderstandthemetabolicmechanismofthedrugsbyCYP3A4.